Concepedia

Hiromi Iitsuka

HI

Statistics

Publications

5

Citations

127

H-Index

5

Active since

2012

Affiliations

Astellas Pharma (Japan)(Current)

Astellas Pharma (Netherlands)

Hiromi Iitsuka is an author at Astellas Pharma (Japan) specializing in clinical pharmacology, pharmacology, and pharmacokinetics.

Publications per year

2012–2020

5

Publications

5

Single dose pharmacokinetics and absolute bioavailability of mirabegron, a ?3-adrenoceptor agonist for treatment of overactive bladder

Charlotte Eltink, Jennifer Lee, Marloes Schaddelee et al. · International Journal of Clinical Pharmacology and Therapeutics · 2012 · 54 citations

, , +12

Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy Japanese Male Subjects: Results from Single- and Multiple-Dose Studies

Hiromi Iitsuka, Tomoaki Tokuno, Yoko Amada et al. · Clinical Drug Investigation · 2013 · 30 citations · Full text

, , +14

Pharmacokinetics of Mirabegron, a β3-Adrenoceptor Agonist for Treatment of Overactive Bladder, in Healthy East Asian Subjects

Hiromi Iitsuka, Marcel van Gelderen, Masataka Katashima et al. · Clinical Therapeutics · 2015 · 20 citations · Full text

, , +14

Pharmacokinetic drug interaction study between overactive bladder drugs mirabegron and tolterodine in Japanese healthy postmenopausal females

Yuki Nomura, Hiromi Iitsuka, Junko Toyoshima et al. · Drug Metabolism and Pharmacokinetics · 2016 · 12 citations

, , +13

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study

Masaomi Takizawa, Toshifumi Hatta, Hiromi Iitsuka et al. · Clinical Therapeutics · 2020 · 11 citations

, , +7

1–5 of 5